These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 23122981)

  • 1. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma.
    Yang H; Hu W; Wang W; Chen P; Ding W; Luo W
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e47-54. PubMed ID: 23122981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
    Zhou X; Wang W; Zhou C; Zhu J; Ding W; Chen M; Chen K; Shi Y; Chen X; Kong FM; Yang H
    Radiother Oncol; 2022 May; 170():136-142. PubMed ID: 35288229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma.
    Zhao L; Wan Q; Zhou Y; Deng X; Xie C; Wu S
    Radiother Oncol; 2011 Jan; 98(1):23-7. PubMed ID: 21040992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.
    Wang W; Yang H; Hu W; Shan G; Ding W; Yu C; Wang B; Wang X; Xu Q
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):617-21. PubMed ID: 20138444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue.
    Niu X; Chang X; Gao Y; Hu C; Kong L
    Radiat Oncol; 2013 Oct; 8():226. PubMed ID: 24083351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study.
    Yan D; Yan S; Wang Q; Liao X; Lu Z; Wang Y
    BMC Cancer; 2013 Nov; 13():548. PubMed ID: 24237861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Lu J; Ma Y; Chen J; Wang L; Zhang G; Zhao M; Yin Y
    J Radiat Res; 2014 Jan; 55(1):97-104. PubMed ID: 23728319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
    Gai X; Wei Y; Tao H; Zhu J; Li B
    Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China.
    Zhou X; Zhu J; Zhou C; Wang W; Ding W; Chen M; Chen K; Li S; Chen X; Yang H
    Radiat Oncol; 2023 Nov; 18(1):190. PubMed ID: 37974274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-modulated radiotherapy provides better quality of life than two-dimensional conventional radiotherapy for patients with stage II nasopharyngeal carcinoma.
    Pan XB; Huang ST; Chen KH; Jiang YM; Ma JL; Qu S; Li L; Chen L; Zhu XD
    Oncotarget; 2017 Jul; 8(28):46211-46218. PubMed ID: 28515352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
    Hansen EK; Bucci MK; Quivey JM; Weinberg V; Xia P
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):355-62. PubMed ID: 16256277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SU-E-T-550: Influence of the Clinical Outcome and Quality of Life by Replanning during Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma.
    Yang H; Hu W; Wang W; Chen P
    Med Phys; 2012 Jun; 39(6Part18):3832. PubMed ID: 28518508
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
    Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma: A Randomized Clinical Trial.
    Tang LL; Guo R; Zhang N; Deng B; Chen L; Cheng ZB; Huang J; Hu WH; Huang SH; Luo WJ; Liang JH; Zheng YM; Zhang F; Mao YP; Li WF; Zhou GQ; Liu X; Chen YP; Xu C; Lin L; Liu Q; Du XJ; Zhang Y; Sun Y; Ma J
    JAMA; 2022 Aug; 328(8):728-736. PubMed ID: 35997729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
    Luo Y; Gao Y; Yang G; Lang J
    Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma?
    Chen C; Lin X; Pan J; Fei Z; Chen L; Bai P
    Jpn J Radiol; 2013 Sep; 31(9):593-9. PubMed ID: 23749480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.